XOM · Forward model · Guyana case
The Guyana case, 20 quarters out
Model as of
Each segment is projected from its own operating driver, rolled up into consolidated cash flow, and discounted back to a fair value per share. The assumptions below are editable — change them and every number on this page moves with them.
Five verticals - the four reportable segments net of intersegment eliminations plus the Corporate-and-Financing non-segment line - are the finest honest cut. They sum to reported Total revenues and other income to the dollar in all ten quarters from 2024 Q1 to 2026 Q2, which is the whole history available on this presentation: the segment note carrying the reconciling basis begins with the 2025 filings, whose comparatives reach 2024 Q1. Two quarters are marked estimated, 2024 Q4 and 2025 Q4, because they were derived by subtracting a nine-month figure from a full-year one; both reconcile to the quarterly revenue already stored in data/companies/xom/series.json. No Permian-versus-Guyana split, no refining-versus-trading split and no polyethylene-versus-performance-chemicals split is attempted, because none is disclosed. Low Carbon Solutions has no revenue line at all and is not given one. Disclosed and copied as reported: segment revenue, segment volumes, realisations and markers, per-segment cash capex, the annual earnings sensitivities, the 3Q26 key items and the 2026 and 2030 volume, capex, cost-savings and buyback plans. Assumed and labelled as such: every forward price path, the terminal margins and capex intensities, the 30% tax rate, the 9% discount rate and the 9.0x exit multiple. All five verticals are aseasonal. Fourteen quarters of per-segment third-party sales across three calendar-year windows were tested and no vertical produced a factor whose deviation from 1.0 exceeded its own window-to-window spread - the largest signal is Upstream Q3 at 5.0% against a 66-point spread - so no seasonality vector is asserted. Two arithmetic artefacts are worth stating plainly. Upstream EBITDA is 127% of Upstream reported revenue in the basis quarter because transferred barrels sit in the numerator and not the denominator; the margin is capped at 100% and the $3,664M the cap cannot hold is credited to Energy Products, which buys those barrels, so consolidated EBITDA still reconciles. And the disclosed per-tonne unit-earnings figures for Chemical and Specialty Products cannot be reconciled to reported segment earnings - ~$210/T on 21.3 Mt would imply about $4.5B of 2025 Chemical earnings against the $800M the four 2025 quarters reported - so terminal margins are set from the reported segment note instead. Corporate overhead of 0.78% of revenue is the midpoint of the disclosed $0.8-1.0B of 3Q26 Corporate and Financing expenses. The share count is held flat at the 4,112M outstanding on 30 June; the disclosed ~$20B a year of buybacks would shrink it about 3.6% annually, so the per-share output here is conservative by roughly that much a year. Free cash flow in this model is EBITDA less capex less tax, which is not the company's own non-GAAP free cash flow of $17,236M for the quarter.
Shares this page's scenario. Driver and horizon edits stay in your browser — the recipient sees the published model.
Latest: $87.76B (2031Q2E)
| Period | Value |
|---|---|
| 2024Q1 | $83.08B |
| 2024Q2 | $93.06B |
| 2024Q3 | $90.02B |
| 2024Q4 | $83.43B |
| 2025Q1 | $83.13B |
| 2025Q2 | $81.51B |
| 2025Q3 | $85.29B |
| 2025Q4 | $82.31B |
| 2026Q1 | $85.14B |
| 2026Q2 | $116.02B |
| 2026Q3E | $104.13B |
| 2026Q4E | $97.06B |
| 2027Q1E | $92.44B |
| 2027Q2E | $89.39B |
| 2027Q3E | $87.38B |
| 2027Q4E | $86.08B |
| 2028Q1E | $85.27B |
| 2028Q2E | $84.80B |
| 2028Q3E | $84.58B |
| 2028Q4E | $84.54B |
| 2029Q1E | $84.62B |
| 2029Q2E | $84.80B |
| 2029Q3E | $85.04B |
| 2029Q4E | $85.34B |
| 2030Q1E | $85.68B |
| 2030Q2E | $86.05B |
| 2030Q3E | $86.45B |
| 2030Q4E | $86.87B |
| 2031Q1E | $87.30B |
| 2031Q2E | $87.76B |
Where each case comes from
Bear case — primary sources
The primary sources this case is built from — filings, calls and posts. Where they are claims by an interested party rather than disclosures, every number in the Bear column is what happens if they are taken at face value.
Markers and sensitivities, 2Q26
- Jul 31, 2026 Marker Benchmarks, Brent ($/b) 104.52 for 2Q26, 80.61 for 1Q26, 63.69 for 4Q25, 69.07 for 3Q25
- Jul 31, 2026 Annual Earnings Sensitivities, Upstream, Brent ($/bbl): Increase of $1/bbl = +$700M; Energy Products, Indicative Refining Margin ($/bbl): Increase of $1/bbl = +$800M
- Jul 31, 2026 If the Strait were to be fully closed throughout the third quarter, we expect Middle East production to be reduced by approximately 750 thousand oil-equivalent barrels per day compared with 2025
Bull case — primary sources
The primary sources this case is built from — filings, calls and posts. Where they are claims by an interested party rather than disclosures, every number in the Bull column is what happens if they are taken at face value.
2030 plan, 2Q26 slides
- Jul 31, 2026 On track to deliver 2030 plan: expect ~$25B earnings growth and ~$35B cash flow growth from 2024-2030
- Jul 31, 2026 Upstream Production (Moebd) 4.3 in 2024, 4.7 in 2025, ~4.9 in the 2026 plan and ~5.5 in the 2030 plan
- Jul 31, 2026 Structural cost savings ($B; cumulative versus 2019) 2030 PL ~$20; $16.3 at 2Q26
Guyana case — primary sources
The primary sources this case is built from — filings, calls and posts. Where they are claims by an interested party rather than disclosures, every number in the Guyana column is what happens if they are taken at face value.
Guyana, 2Q26 prepared remarks and release
- Jul 31, 2026 Since 2014, the co-venturers invested more than $55 billion in exploration and development... Stronger performance relative to the investment basis generated more than $13 billion of incremental revenue and cost savings
- Jul 31, 2026 We expect Guyana free cash flow attributable to ExxonMobil to more than double between 2025 and 2030 at constant prices
- Jul 31, 2026 Fifth Guyana FPSO set sail with production startup on plan for 4Q26, increasing capacity by 250 Kbd
From cash flow to fair value
| Present value of free cash flow, 20 quarters | $158.89B |
| Terminal-year revenue | $348.38B |
| Terminal-year EBITDA | $93.32B |
| Exit multiple, on ebitda | 9.5x |
| Terminal value | $886.51B |
| Discounted at 9.0% a year, terminal value becomes | $576.17B |
| Share of enterprise value from the terminal | 78% |
| Enterprise value | $735.06B |
| Net cash | -$31.78B |
| Equity value | $703.28B |
| Shares | 4.11B |
| Fair value per share | $171.03 |
| Against the deployed price of $159.47, as of | +7% |
9% is the cost of equity for an investment-grade major carrying $31.8B of net debt against $266.1B of equity. The 9.0x exit sits between the 9.3x the market pays on trailing EBITDA that contains the spike quarter and the 10.4x the same enterprise value implies against FY2025 EBITDA of $67.9B - and that is the whole argument, because the multiple you believe depends entirely on which EBITDA you think is normal.
Read the other way round: at $159.47 the market is paying 8.7x terminal-year revenue, holding every other assumption on this page fixed. That is the number to argue about.
Capex outside the verticals
Each vertical's capex is a share of its own revenue, which is the right shape for capacity that scales with sales. These are not that: fixed-size programmes with their own schedule that spend whether or not any segment grows. They are added on top, and they are why free cash flow dips in the years below.
Other corporate cash capital expenditures
2026 Q3 → 2031 Q2The Other line of the disclosed per-segment cash capex table: $90M in 2Q26 against $140M in 1Q26. It belongs to no vertical, so it is spread evenly across the twenty projected quarters at the basis-quarter rate rather than tied to a revenue ratio.
The projected path
| Quarter | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate and Financing | Revenue | YoY | EBITDA | Capex | FCF | R40 | PV of FCF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3E | $12.37B | $80.08B | $6.59B | $5.07B | $24M | $104.13B | +22% | $24.67B | $6.77B | $12.53B | +34 | $12.27B |
| 2026 Q4E | $12.14B | $73.74B | $6.26B | $4.88B | $24M | $97.06B | +18% | $22.95B | $6.88B | $11.25B | +30 | $10.78B |
| 2027 Q1E | $12.07B | $69.54B | $6.03B | $4.77B | $24M | $92.44B | +9% | $21.85B | $6.93B | $10.44B | +20 | $9.79B |
| 2027 Q2E | $12.10B | $66.68B | $5.87B | $4.71B | $24M | $89.39B | -23% | $21.15B | $6.97B | $9.93B | -12 | $9.11B |
| 2027 Q3E | $12.21B | $64.69B | $5.77B | $4.68B | $24M | $87.38B | -16% | $20.73B | $7.03B | $9.60B | -5 | $8.62B |
| 2027 Q4E | $12.37B | $63.30B | $5.71B | $4.68B | $24M | $86.08B | -11% | $20.51B | $7.10B | $9.39B | +0 | $8.25B |
| 2028 Q1E | $12.57B | $62.30B | $5.68B | $4.69B | $24M | $85.27B | -8% | $20.43B | $7.20B | $9.26B | +3 | $7.97B |
| 2028 Q2E | $12.80B | $61.59B | $5.68B | $4.72B | $24M | $84.80B | -5% | $20.45B | $7.30B | $9.20B | +6 | $7.75B |
| 2028 Q3E | $13.06B | $61.06B | $5.69B | $4.75B | $24M | $84.58B | -3% | $20.55B | $7.43B | $9.19B | +8 | $7.57B |
| 2028 Q4E | $13.34B | $60.67B | $5.71B | $4.80B | $24M | $84.54B | -2% | $20.71B | $7.56B | $9.20B | +9 | $7.42B |
| 2029 Q1E | $13.64B | $60.38B | $5.74B | $4.84B | $24M | $84.62B | -1% | $20.92B | $7.70B | $9.25B | +10 | $7.30B |
| 2029 Q2E | $13.95B | $60.15B | $5.78B | $4.90B | $24M | $84.80B | +0% | $21.16B | $7.85B | $9.31B | +11 | $7.19B |
| 2029 Q3E | $14.27B | $59.98B | $5.82B | $4.95B | $24M | $85.04B | +1% | $21.44B | $8.01B | $9.40B | +12 | $7.10B |
| 2029 Q4E | $14.61B | $59.83B | $5.87B | $5.01B | $24M | $85.34B | +1% | $21.74B | $8.18B | $9.49B | +12 | $7.02B |
| 2030 Q1E | $14.96B | $59.72B | $5.92B | $5.07B | $24M | $85.68B | +1% | $22.06B | $8.35B | $9.60B | +12 | $6.95B |
| 2030 Q2E | $15.32B | $59.61B | $5.97B | $5.13B | $24M | $86.05B | +1% | $22.40B | $8.52B | $9.71B | +13 | $6.88B |
| 2030 Q3E | $15.69B | $59.52B | $6.02B | $5.19B | $24M | $86.45B | +2% | $22.76B | $8.71B | $9.83B | +13 | $6.82B |
| 2030 Q4E | $16.07B | $59.44B | $6.07B | $5.26B | $24M | $86.87B | +2% | $23.13B | $8.89B | $9.97B | +13 | $6.76B |
| 2031 Q1E | $16.46B | $59.37B | $6.13B | $5.32B | $24M | $87.30B | +2% | $23.52B | $9.08B | $10.10B | +13 | $6.71B |
| 2031 Q2E | $16.86B | $59.30B | $6.19B | $5.39B | $24M | $87.76B | +2% | $23.92B | $9.28B | $10.24B | +14 | $6.66B |
Every row is projected. A year-over-year change is shown only where the quarter it compares against exists — an em dash means there is no comparable quarter, not a flat year.
Model revisions
Assumptions are marked to reality as each quarter prints. Every change is appended here, with the fair value the model produced at the time, so the model's own history stays visible.
| Date | Fair value then | Note |
|---|---|---|
| 2026-08-27 | $150.65 | First published model, built from the 2026 Q2 research brief: five reconciling verticals, four unit drivers on disclosed volumes and a growth line for Corporate and Financing. |